Dr. Sara Elisabeth Halverson, MD

Dr. Halverson practices at Ech: Mri Pro Plaza - Mri - HOPD in Loma Linda, California.

Dr. Halverson's NPI, 1427291004, was assigned on April 13, 2009. Dr. Halverson graduated from Loma Linda University School Of Medicine in 2009. Dr. Halverson holds California license A113167.

Dr. Halverson's primary practice is Ech: Mri Pro Plaza - Mri - HOPD, at 25455 Barton Rd, Loma Linda, CA 92354.

Dr. Halverson's primary practice is Ech: Mri Pro Plaza - Mri - HOPD in Loma Linda, California. Dr. Halverson is also affiliated with Loma Linda University Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Halverson to 2 more group practices and clinics, 2 home health agencies and 1 medical group, each named with a free account. Dr. Halverson's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Halverson practices, 6 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Halverson's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Halverson is board certified in family medicine by the American Board of Family Medicine. Dr. Halverson is licensed in California.

Dmand AI lists acute skin infection, alzheimer's disease, atrial fibrillation and flutter, bursitis, chronic anemia, chronic diabetes, chronic hypertension and chronic kidney disease among the conditions Dr. Halverson treats.

CMS data shows 415 Medicare services from Dr. Halverson across 7 procedure codes in 2024, for 181 Medicare patients. Medicare paid $37,563 for them. Every service was in an office.

CMS counts 181 Medicare patients who saw Dr. Halverson in 2024. The largest group is 75 to 84, with 77 patients. 70% of them have high blood pressure, and 64% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Halverson's median patient age at 68, with 78% women.

In 2024, Dr. Halverson wrote 2,458 Medicare Part D claims for 317 patients. 86% of them were for generic drugs. CMS names the drug for 1,787 of them, across 54 drugs with 11 or more claims each, at $161,954 in total drug cost. In 2023, CMS named 2,313 claims across 66 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Halverson for performance year 2024, reported as part of a group. Dr. Halverson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Halverson as offering telehealth.

Dmand AI links 2 papers to Dr. Halverson. Dr. Halverson has published most often in Prim Care. Dr. Halverson's most frequent co-authors are Hobart Hong Lee, MD, Ngozi Margarete Ezinwa, MD and Regina Maria Mackey, MD.

CMS Open Payments shows 4 general payments to Dr. Halverson from 2 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $88.

Dmand AI lists 1 award for Dr. Halverson, most recently CMS Stage 1 EHR in 2013.

Dr. Halverson graduated from Loma Linda University School Of Medicine in 2009.

Dr. Halverson is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.